This company has been acquired
Neovasc Crecimiento futuro
Future controles de criterios 0/6
Información clave
n/a
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Medical Equipment | 16.4% |
| Tasa de crecimiento de los ingresos | n/a |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 10 Feb 2023 |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2023 | 10 | -23 | N/A | N/A | 1 |
| 12/31/2022 | 4 | -41 | -25 | -25 | N/A |
| 9/30/2022 | 3 | -34 | -24 | -24 | N/A |
| 6/30/2022 | 3 | -33 | -25 | -25 | N/A |
| 3/31/2022 | 3 | -33 | -26 | -25 | N/A |
| 12/31/2021 | 3 | -25 | -27 | -27 | N/A |
| 9/30/2021 | 2 | -23 | -30 | -29 | N/A |
| 6/30/2021 | 2 | -26 | -31 | -31 | N/A |
| 3/31/2021 | 2 | -27 | -32 | -31 | N/A |
| 12/31/2020 | 2 | -29 | -30 | -29 | N/A |
| 9/30/2020 | 2 | -37 | -29 | -29 | N/A |
| 6/30/2020 | 2 | -33 | -27 | -27 | N/A |
| 3/31/2020 | 2 | -31 | -25 | -25 | N/A |
| 12/31/2019 | 2 | -35 | -24 | -24 | N/A |
| 9/30/2019 | 2 | -11 | -24 | -24 | N/A |
| 6/30/2019 | 2 | -20 | -23 | -23 | N/A |
| 3/31/2019 | 2 | -61 | -24 | -24 | N/A |
| 12/31/2018 | 2 | -108 | -23 | -23 | N/A |
| 9/30/2018 | 2 | -125 | -141 | -141 | N/A |
| 6/30/2018 | 3 | -115 | -140 | -140 | N/A |
| 3/31/2018 | 4 | -71 | -138 | -138 | N/A |
| 12/31/2017 | 5 | -22 | -139 | -139 | N/A |
| 9/30/2017 | 7 | 19 | -22 | -21 | N/A |
| 6/30/2017 | 9 | -5 | -29 | -28 | N/A |
| 3/31/2017 | 9 | -83 | -36 | -35 | N/A |
| 12/31/2016 | 10 | -86 | -40 | -40 | N/A |
| 9/30/2016 | 9 | -131 | N/A | -39 | N/A |
| 6/30/2016 | 8 | -110 | N/A | -35 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Insufficient data to determine if NVCN's forecast earnings growth is above the savings rate (1.8%).
Beneficios vs. Mercado: Insufficient data to determine if NVCN's earnings are forecast to grow faster than the Canadian market
Beneficios de alto crecimiento: Insufficient data to determine if NVCN's earnings are expected to grow significantly over the next 3 years.
Ingresos vs. Mercado: Insufficient data to determine if NVCN's revenue is forecast to grow faster than the Canadian market.
Ingresos de alto crecimiento: Insufficient data to determine if NVCN's revenue is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if NVCN's Return on Equity is forecast to be high in 3 years time